$1.51
0.074.86%
Pre-Market: 4:24 PM EDT
Comments
Loading...
Climb Bio (CLYM) Forecast
NewsEarningsClimb Bio (CLYM) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestClimb Bio (NASDAQ:CLYM) Stock Quotes, Forecast and News Summary
Climb Bio Stock (NASDAQ: CLYM) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Climb Bio (CLYM) stock?
You can purchase shares of Climb Bio (NASDAQ:CLYM) through any online brokerage.
Who are Climb Bio (CLYM) competitors?
Other companies in Climb Bio’s space includes: Zura Bio (NASDAQ:ZURA), Cabaletta Bio (NASDAQ:CABA), Anixa Biosciences (NASDAQ:ANIX), Skye Bioscience (NASDAQ:SKYE) and Galectin Therapeutics (NASDAQ:GALT).
What is the forecast, or price target, for Climb Bio (CLYM) stock?
There is no analysis for Climb Bio to provide a consensus price target.
What is the current price for Climb Bio (CLYM)?
The stock price for Climb Bio (NASDAQ: CLYM) is $1.51 last updated February 20, 2025 at 4:24 PM EST.
Does Climb Bio (CLYM) pay a dividend?
There are no upcoming dividends for Climb Bio.
When is Climb Bio (NASDAQ:CLYM) reporting earnings?
Climb Bio’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
Is Climb Bio (CLYM) going to split?
There is no upcoming split for Climb Bio.
What sector and industry does Climb Bio (CLYM) operate in?
Climb Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.